title: The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab.
authors: Arzu Didem
authors: AD
authors: Yalcin
authors: Atil
authors: A
authors: Bisgin
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D000069444:Omalizumab; D011788:Quality of Life; D012995:Solubility; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000097:blood*
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D053221:TNF-Related Apoptosis-Inducing Ligand; D000069444:Omalizumab